Welcome to Waterland
Waterland is an independent private equity investment group that supports entrepreneurs in realizing their growth ambitions. With substantial financial resources and committed industry expertise, Waterland enables its portfolio companies to achieve accelerated growth both organically and through acquisitions. Waterland is an active investor in the financial, strategic and operational sense.
In the current dynamic business environment with an increasing number of (cross border) mergers and acquisitions, Waterland is a partner that provides entrepreneurs with a powerful position in the increasingly competitive international arena. In the meantime Waterland has made investments in over 300 companies. Waterland currently manages € 4 billion of investor commitments . In addition, Waterland has access to extensive leveraged finance funding.
Waterland is member of the Dutch Venture Capital Association (NVP), the Belgian Venturing Association (BVA), the European Private Equity & Venture Capital Association (EVCA), the German Private Equity and Venture Capital Association e.V. (BVK), Polskie Stowarzyszenie Inwestorow Kapitalowych (PSIK), the Austrian Private Equity & Venture Capital Organisation (AVCO) and the Swiss Private Equity & Corporate Finance Association (SECA).
Waterland has offices in Bussum (The Netherlands), Antwerp (Belgium), Düsseldorf and Munich (Germany) and Warsaw (Poland).
Waterland Private Equity Investments (“Waterland”) is pleased to announce the closing of its sixth institutional fund, Waterland Private Equity Fund VI (“WPEF VI”) at €1.25 billion and WPEF VI Overflow Fund at €300 million, just three months after its initial launch. The strong support of existing investors combined with significant interest from new investors, caused the fund to be well oversubscribed.
The fundraising attracted commitments from world class institutional investors from Europe (40%), the United States (40%), Middle East (10%) and Asia Pacific (10%). Pension plans represent the largest proportion of the investor base.
WPEF VI expects to make control investments in medium-sized quality companies in fragmented growth markets in the target region consisting of Belgium, Luxembourg, the Netherlands, Germany, Austria, Switzerland and Poland to finance organic and acquisitive growth. This is a continuation of the successful buy-and-build investment strategy applied to the Firm’s prior funds over the last fifteen years. Waterland is able to deploy the Overflow Fund in situations where WPEF VI reaches its concentration limits.
Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company
DUBLIN, March 30, 2015 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it has completed the acquisition of Belgian-based Omega Pharma Invest N.V. ("Omega") in a cash and equity transaction valued at approximately €3.8 billion, which includes the assumption of €1.3 billion in debt. Sellers are Marc Coucke, Waterland Private Equity Fund V CV and co-investors of Waterland.
"The combination of Perrigo and Omega creates an industry leading, global healthcare company with the operational structure and cash flow generation to accelerate our international growth even further," said Perrigo Chairman, President and CEO, Joseph C. Papa. "This strategic combination creates a top 5 global OTC healthcare company by revenue, enhancing our leading OTC position through Omega's strong, established European commercial, regulatory and distribution platforms, which further enables us to capitalize on the many megatrends which bend in favor of consumer choice and cost control in healthcare. We expect the combined companies will create tremendous value for consumers and shareholders for years to come."